770 ADU-1604, a novel CTLA-4 blocking antibody modulates pharmacodynamic markers in PD1 relapse/refractory melanoma patients by Caroline Robert, Ivan Marquez-Rodas, Michele Maio, Vanna Chiarion-Sileni, Piotr Rutkowski, Hans Van Eenennaam, Julien Villaudy, Jessica Kundapur, Ana Maria Arance, Alexander Eggermont, Guillemo De Velasco Oria de Rueda, Laura Lassouw-Polman